Select Page

The coming of age of 3D bioprinting?

The coming of age of 3D bioprinting?

Written by David

December 22, 2018

Though activities in 3D bioprinting have been growing in leaps and bounds since 2015, the activity we have seen in 2018 has been truly remarkable for this fledgling field. Finally, governments, academic institutions and companies alike are beginning to understand the value that 3D bioprinting can bring and are working hard together to bring disruptive change through building tissues from scratch. Please refer to IDTechEx’s report, 3D Bioprinting 2018 – 2028 for more information. Uptake of 3D bioprinting in pharmaceutical testing One of the key markets for 3D bioprinted tissues, especially in the short- to medium-term before the approval of 3D bioprinted tissues for implantation, is in pharmaceutical testing. 3D bioprinted tissues have the potential to provide more relevant results in preclinical testing of drugs than the current techniques of 2D cell culture and animal testing. Certainly, pharmaceutical and biotechnology companies have been working with Organovo on their liver […]


Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!